Trials / Completed
CompletedNCT01113866
Biomarkers for Prognosis of Ambulatory Chronic Heart Failure Patients
Circulating Biomarkers as Prognostic Indicators of Death in Ambulatory Heart Failure Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 124 (actual)
- Sponsor
- University of Parma · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Biomarkers representing distinct biological domains including neurohormonal, inflammatory, metabolic-nutritional, oxidative-nitrosative and myocardial injury, might alone or in combination provide prognostic information on mortality in heart failure patients with preserved or impaired systolic function.
Detailed description
Upon enrollment in the study, Troponin I (cTn I), BNP, norepinephrine, plasma renin activity, aldosterone, high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), soluble receptor of interleukin 2 (sIL-2R), leptin, prealbumin, free malondialdehyde, 15-F2t-isoprostane and protein-bound nitrotyrosine were measured in stable ambulatory, non diabetic, elderly heart failure patients. Patients were followed up until death or study termination (31st January 2009).
Conditions
Timeline
- Start date
- 1998-10-01
- Primary completion
- 2003-05-01
- Completion
- 2009-01-01
- First posted
- 2010-04-30
- Last updated
- 2010-05-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01113866. Inclusion in this directory is not an endorsement.